Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04552639
Other study ID # 281456
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2020
Est. completion date December 31, 2022

Study information

Verified date September 2021
Source Newbridge House
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study aims to generate hypotheses about whether a group intervention is effective in reducing motivation to compulsive exercise and/or eating disorder psychopathology when compared with a control group. This will be explored through a Randomized Control Trial.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date December 31, 2022
Est. primary completion date October 1, 2022
Accepts healthy volunteers No
Gender Female
Age group 11 Years to 18 Years
Eligibility Inclusion Criteria: - Inpatients at Newbridge House - Aged 11-18 - Primary diagnosis of any form of eating disorder - Females Exclusion Criteria: - Previously received NEAT group at Newbridge House - Aged under 10 years - Severe learning disability - Inpatients without compulsive exercise behaviours - Day patients - Co-morbid psychosis - Males

Study Design


Intervention

Behavioral:
Newbridge Eating disorders Activity Treatment group
A compulsive exercise cognitive-behavioural based group, for children and adolescents diagnosed with an eating disorder. It was devised for eating disorders including Anorexia Nervosa, Bulimia Nervosa and Other Specified Feeding or Eating Disorder. This treatment is semi-structured and problem-oriented, which focuses on tackling the factors and processes that maintain compulsive exercise behaviour.
Newbridge House treatment as usual
Multi-disciplinary eating disorder treatment (including; psychiatry, individual therapy, group therapy, dietetic support, occupation therapy and nursing excluding NEAT group).

Locations

Country Name City State
United Kingdom Newbridge House Birmingham

Sponsors (1)

Lead Sponsor Collaborator
Newbridge House

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Compulsive Exercise Test Week 1 and week 7
Secondary Change in Eating Disorder Examination Questionnaire Week 1 and week 7
See also
  Status Clinical Trial Phase
Completed NCT04591886 - The Peer-Delivered "Mind. Body. Voice." Program for High School Women N/A
Completed NCT03097874 - Adaptive Treatment for Adolescent Anorexia Nervosa N/A
Completed NCT04591912 - The Peer-Delivered "Mind. Body. Voice." Program for High School Women (Mbv) - Remote N/A
Recruiting NCT06431854 - Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program N/A
Completed NCT05554458 - Implementation and Evaluation of the ChildTaks+ Intervention in the Czech Republic N/A
Completed NCT05091983 - Restrictive Eating Disorders: From Childhood Orality Disorder to Adolescent Dysensoriality
Active, not recruiting NCT04127214 - The ITA Model of Integrated Treatment of Eating Disorders
Completed NCT04888273 - Assessing the Feasibility of an Intervention for Youth and Parents Transitioning to Adult Eating Disorder Services N/A
Recruiting NCT03563755 - Social Information Processing in Adolescents With Eating Disorders N/A
Active, not recruiting NCT05780242 - Recrudescence of Eating Conduct Disorders and Covid-19
Active, not recruiting NCT03693911 - ACT to Prevent Eating Disorders: Evaluating a Gamified Prevention Program N/A
Recruiting NCT03855553 - Project CORE: Disseminating Eating Disorders Treatment Phase 1
Completed NCT04088097 - Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating N/A
Completed NCT04263155 - The Peer-Delivered Body Project for Young Women in High School N/A
Completed NCT06039514 - Mobile App for Eating Disorders in Adolescents N/A
Enrolling by invitation NCT04869423 - Animal-Assisted Therapy in Adolescents With Eating Disorders N/A
Terminated NCT05073679 - Oral Naltrexone In Pediatric Eating Disorders Phase 2/Phase 3